Optimizing drug discovery in a fast-moving market

In 2021, over 200 biopharma executives were surveyed about changing approaches to building biologic drug development pipelines. Organizations are now considering different approaches, focusing on where and how they conduct their development progra…

Optimizing drug discovery in a fast-moving market

In 2021, over 200 biopharma executives were surveyed about changing approaches to building biologic drug development pipelines. Organizations are now considering different approaches, focusing on where and how they conduct their development progra…

A Buyer’s Guide to Securing Privileged Access

In this buyer’s guide to privileged access management, learn the seven criteria you need to look for in a vendor such as support for a hybrid infrastructure, user experience, broad ecosystem and ability to defend against advanced threats dur…